Paul A. VanderLaan
-
- Lung Cancer Treatments and Mutations 59
- Lung Cancer Diagnosis and Treatment 38
- Medical Imaging and Pathology Studies 12
- Oncology top 2%
- Lung Cancer Research Studies 13
-
- Thyroid Cancer Diagnosis and Treatment 17
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 19
- Surgery top 5%
- Salivary Gland Tumors Diagnosis and Treatment 13
- Head and Neck Anomalies 13
- Co-authors
- Catherine A. ReardonGodfrey S. GetzDaniel B. CostaJeffrey F. KraneDeepa RangachariMark S. HubermanEllen MarquseeErik Folch
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (4 papers)
- Partner nations
- United StatesAustriaJapan
In The Last Decade
Paul A. VanderLaan
135 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Pulmonary and Respiratory Medicine 2.1k
- Oncology 1.3k
- Endocrinology, Diabetes and Metabolism 778
- Cancer Research 612
- Surgery 1.1k
Countries citing papers authored by Paul A. VanderLaan
This map shows the geographic impact of Paul A. VanderLaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. VanderLaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. VanderLaan more than expected).
Fields of papers citing papers by Paul A. VanderLaan
This network shows the impact of papers produced by Paul A. VanderLaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. VanderLaan. The network helps show where Paul A. VanderLaan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul A. VanderLaan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 12 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 16 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 10 | |
| 18 | 2020 | 19 | |
| 19 | 2019 | 34 | |
| 20 | 2017 | 1 |
About Paul A. VanderLaan
Paul A. VanderLaan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 150 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Diagnosis and Treatment (38 papers), Cancer Genomics and Diagnostics (19 papers), Thyroid Cancer Diagnosis and Treatment (17 papers), Salivary Gland Tumors Diagnosis and Treatment (13 papers), Head and Neck Anomalies (13 papers), Lung Cancer Research Studies (13 papers) and Medical Imaging and Pathology Studies (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.1k citations), Oncology (1.3k citations) and Endocrinology, Diabetes and Metabolism (778 citations). Paul A. VanderLaan has collaborated with scholars based in United States, Austria and Japan. Frequent co-authors include Catherine A. Reardon, Godfrey S. Getz, Daniel B. Costa, Jeffrey F. Krane, Deepa Rangachari, Mark S. Huberman, Ellen Marqusee, Erik Folch, Susumu Kobayashi and Adnan Majid. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.